, Tracking Stock Market Picks
Enter Symbol:
Neurobiological Technologies, Inc. (NTII) [hlAlert]

down 97.82 %

Neurobiological Technologies, Inc. (NTII) rated Buy by Merriman Curhan Ford

Posted on: Thursday,  Jun 5, 2008  8:25 AM ET by Merriman Curhan Ford

Merriman Curhan Ford rated Buy Neurobiological Technologies, Inc. (OTCBB: NTII) on 06/05/2008, when the stock price was $1.84.
Since then, Neurobiological Technologies, Inc. has lost 97.83% as of 08/27/2015's recent price of $0.04.
If you would have followed this Merriman Curhan Ford's recommendation on NTII, you would have lost 97.82% of your investment in 2639 days.

Neurobiological Tech. is an emerging drug development company focused on the clinical evaluation and regulatory approval of neuroscience drugs. The company's strategy is to in-license and develop early-stage drug candidates that target major medical needs and which can be rapidly commercialized.

We occupy a unique niche among our investment banking peers: we offer our clients both traditional sell-side equity research and primary market research, and we focus on high-potential sectors such as CleanTech, Consumer/Internet/Media, Health Care and Tech/Telecom. Our institutional and corporate clients get the best of both worlds: expertise from our analysts and access to experts through our Panel Intelligence platform.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/5/2008 8:25 AM Buy
as of 12/24/2008
1 Week down  -3.70 %
1 Month up  27.86 %
3 Months up  25.80 %
1 YTD up  151.61 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy